z-logo
Premium
Azathioprine‐induced lymphocytic neoplasms of NZB mice lack ecotropic murine leukaemia virus
Author(s) -
Harvey Jennifer J.,
East June,
Katz Fay E.
Publication year - 1979
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910230213
Subject(s) - azathioprine , virus , virology , biology , lymphocytic choriomeningitis , in vitro , cell culture , genome , immunology , cancer research , pathology , medicine , gene , genetics , disease , cytotoxic t cell
NZB mice injected intramuscularly throughout a 6‐month period with the immunosuppressant azathioprine (Imuran) developed lymphocytic lymphomas 6–7 months after treatment was initiated. These malignancies were quite distinct from the reticulum‐cell neoplasia which occurs spontaneously in the strain, and were readily transplantable to NZB or histocompatible BALB/c recipients. Xenotropic, but not ecotropic murine leukaemia virus (MuLV) was detected in leukaemic tissues of some donor and recipient NZBs when tested in vitro by co‐cultivation with permissive cell lines, genome rescue, XC and viral polymerase assays. Virus filtrates prepared from donor leukaemic tissues were non‐pathogenic when injected into newborn C3H mice. These results are evidence against a mandatory ecotropic MuLV genome in lymphocytic neoplasia.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here